Topical chemotherapy with 5-fluorouracil : A review - 07/10/17
Doi : 10.1016/S0190-9622(81)80196-X
Résumé |
Since its introduction in the early 1960s as a topical chemotherapeutic agent, 5-fluorouracil (FU) has become increasingly accepted because of its efficacy, economy, good cosmetic results, and relative absence of side effects in treating many precancerous conditions and certain benign and malignant tumors and dermatoses. With wider use of FU, new indications and a greater array of side effects have precipitated an avalanche of literature, a review of which is the subject of this paper.
Le texte complet de cet article est disponible en PDF.| * | The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. |
| † | Reprints not available. |
© 1981
Publié par Elsevier Masson SAS.
Vol 4 - N° 6
P. 633-649 - juin 1981 Retour au numéro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?